Rigamonti, A.E.; Dei Cas, M.; Caroli, D.; Bondesan, A.; Cella, S.G.; Paroni, R.; Sartorio, A.
Ceramide Risk Score in the Evaluation of Metabolic Syndrome: An Additional or Substitutive Biochemical Marker in the Clinical Practice? Int. J. Mol. Sci. 2023, 24, 12452.
https://doi.org/10.3390/ijms241512452
AMA Style
Rigamonti AE, Dei Cas M, Caroli D, Bondesan A, Cella SG, Paroni R, Sartorio A.
Ceramide Risk Score in the Evaluation of Metabolic Syndrome: An Additional or Substitutive Biochemical Marker in the Clinical Practice? International Journal of Molecular Sciences. 2023; 24(15):12452.
https://doi.org/10.3390/ijms241512452
Chicago/Turabian Style
Rigamonti, Antonello E., Michele Dei Cas, Diana Caroli, Adele Bondesan, Silvano G. Cella, Rita Paroni, and Alessandro Sartorio.
2023. "Ceramide Risk Score in the Evaluation of Metabolic Syndrome: An Additional or Substitutive Biochemical Marker in the Clinical Practice?" International Journal of Molecular Sciences 24, no. 15: 12452.
https://doi.org/10.3390/ijms241512452
APA Style
Rigamonti, A. E., Dei Cas, M., Caroli, D., Bondesan, A., Cella, S. G., Paroni, R., & Sartorio, A.
(2023). Ceramide Risk Score in the Evaluation of Metabolic Syndrome: An Additional or Substitutive Biochemical Marker in the Clinical Practice? International Journal of Molecular Sciences, 24(15), 12452.
https://doi.org/10.3390/ijms241512452